ArticleGlobal & regional health technology assessment

Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain.

Margarita Majem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.